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E-mail address: claudiosabbatini@uol.com.br (C.C.The preparation of the alkaloid quindoline (1) from indol (3) through a very direct synthetic approach is
described in this work. Several successive heteroaromatic lithiation reaction steps were performed in the
same medium producing benzylic alcohol (7) in excellent yield. The alcohol was submitted to catalytic
reduction, undergoing concomitant cyclization and aromatization, yielding quindoline (1) in 55% overall
yield.






Cl-The [3,2-b] indolo-quinoline alkaloids are relatively rare in nat-
ure. Quindoline (1) possesses the simplest structure of this class of
compounds and can be isolated from the species Cryptolepis sangu-
inolenta (Lind.), family Asclepiadaceae, together with its natural
derivative cryptolepine (2) (Fig. 1).1
The aqueous extract of the root and leaves of this species is used
traditionally in West and Central Africa for treatment of malaria
and other diseases.2 Several reports are available in the literature
describing the pharmacological activity of the [3,2-b] indolo-quin-
oline alkaloids, revealing important biological activities, such as
antifungal, hypoglycemic, and antitumoral.3–5
The ﬁrst synthesis of quindoline (1) was achieved by Fichter and
Boehringer in 1906.6 Since this work, several research groups have
developed alternative syntheses for the preparation of this natural
product and derivatives through approaches involving cross-cou-
pling reactions catalyzed by palladium,7 reductive cyclization
mediated by transition metals,8 and photochemical reactions,9
among others.4,10 These synthetic routes require a large number
of steps via complicated synthetic disconnections or expensive re-
agents and low overall yields in addition to starting reagents that
need previous preparation.7–11
Here, we report an extraordinarily concise total synthesis of
quindoline in two steps from indole and o-nitrobenzaldehyde.
Our route to the natural product is based on the C-2 lithiation of
indole (3). Typically, such lithiations are carried out with a protec-
tive and directing group linked to the indole nitrogen that must bell rights reserved.
ral do Rio de Janeiro, Instituto
loco A, s. 508, Rio de Janeiro,
Lopes).easily removed subsequently.12 In the case of aromatic or heteroar-
omatic lithiation reactions, some of these groups can be very useful
in a range of regioselective functionalization types as ortho-metal-
lation directing agents.13
One of the most elegant methods to promote indole C-2 lithia-
tion was developed by Katritzky, using carbon dioxide as the N-
protecting group. In this procedure, the N-protecting group is in-
serted in situ and removed upon workup at the end of the reaction,
eliminating a separate deprotection step. 14
We treated indole (3) dissolved in THF with 1.1 equiv of n-butyl
lithium at 70 C, leading to the formation of 1-lithio-indole (4)
Scheme 1.
A stream of carbon dioxide gas was then passed through the
reaction medium to protect the indole nitrogen as the lithium car-
bamoyl anion and also direct the metallation reaction at position
C2. In Katritzky’s work, the reagent tert-butyl lithium is used for
the C-2 metallation. Instead, we employed sec-butyl lithium as it
is more stable and of lower cost. The reaction between 5 andquindoline (1) cryptolepine (2)



















































Scheme 1. Synthesis of quindoline (1). Reagents and conditions: (i) n-butyl lithium, THF 70 C, 30 min; (ii) CO2, THF, 10 min; (iii) sec-butyl lithium, THF, 70 C, 1 h; (iv) o-
nitrobenzaldehyde, THF, 70 C, 1 h; H2O; (v) H2 35 psi, Pd–C, CH3OH, CHCl3 (drops), 12 h.
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which upon treatment with 1.0 equiv of the electrophile o-nitro-
benzaldehyde and workup, produced the desired alcohol 7 in 92%
yield.
To our delight, catalytic hydrogenation of the nitro group in 7
directly yielded the natural product quindoline (1) in 60% yield.
The reduction was performed in methanol containing a few drops
of chloroform, with the purpose of generating catalytic amounts of
hydrochloric acid in the reaction medium.15 Under these reaction
conditions, we believe intermediate (8) undergoes intramolecular
cyclization to (9) through nucleophilic attack16 by the aniline with
parallel elimination of a molecule of water. Subsequently, isomer-
ization of the exo double bound leads via the cationic intermediate
(10) to dihydroquinoline (11) with the restoration of aromaticity.17
The unusual dehydrogenation reaction of the dihydroquinoline
(11), presumably was mediated by Pd–C. A similar dehydrogena-
tion/aromatization reaction in hydrogen atmosphere using Pd–C
as catalyst was also described by Moggridge & Plant in the conver-
sion of tetrahydrocarbazoles to carbazoles.18
Overall, our short sequence leads to quindoline (1) in only two
steps and 55% yield from indole (3).19,20 The efﬁciency of our route
enabled the preparation of 1 on a millimolar scale, and holds prom-
ise for the preparation of additional indolo[3,2-b]quinoline deriva-
tives for the purpose of evaluation in multiple biological assays.
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